DE3686390T2 - Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes. - Google Patents

Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes.

Info

Publication number
DE3686390T2
DE3686390T2 DE8686115463T DE3686390T DE3686390T2 DE 3686390 T2 DE3686390 T2 DE 3686390T2 DE 8686115463 T DE8686115463 T DE 8686115463T DE 3686390 T DE3686390 T DE 3686390T DE 3686390 T2 DE3686390 T2 DE 3686390T2
Authority
DE
Germany
Prior art keywords
ahf
fibrinogen
fibronectin
product
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686115463T
Other languages
English (en)
Other versions
DE3686390D1 (de
Inventor
Maria Erlinda C Sarno
Clifford R Graf
Rodolfo A Vasquez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25168481&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3686390(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of DE3686390D1 publication Critical patent/DE3686390D1/de
Publication of DE3686390T2 publication Critical patent/DE3686390T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
DE8686115463T 1985-11-08 1986-11-07 Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes. Expired - Lifetime DE3686390T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79655985A 1985-11-08 1985-11-08

Publications (2)

Publication Number Publication Date
DE3686390D1 DE3686390D1 (de) 1992-09-17
DE3686390T2 true DE3686390T2 (de) 1993-03-04

Family

ID=25168481

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686115463T Expired - Lifetime DE3686390T2 (de) 1985-11-08 1986-11-07 Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes.

Country Status (9)

Country Link
US (1) US4739039A (de)
EP (1) EP0221566B1 (de)
JP (1) JPH0822879B2 (de)
AT (1) ATE79266T1 (de)
AU (1) AU6487286A (de)
CA (1) CA1293941C (de)
DE (1) DE3686390T2 (de)
ES (1) ES2051686T3 (de)
ZA (1) ZA868516B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3806562A1 (de) * 1988-03-01 1989-09-14 Alpha Therapeutic Gmbh Zweikammerspritze mit einer fuellung aus aktivitaetsempfindlichem humanen protein als wirkstoff
DK0399321T3 (da) * 1989-05-24 1993-08-09 Miles Inc Gelfiltrering af varmebehandlet faktor VIII
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5259971A (en) * 1992-03-02 1993-11-09 Cryolife, Inc. Method of preparing fibrinogen
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
US5523893A (en) * 1994-08-24 1996-06-04 Northrop Grumman Corporation Strain free temperature-compensated optical mounts
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
CA2634664C (en) 1999-02-22 2011-08-09 University Of Connecticut Novel albumin-free factor viii formulations
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
KR102356757B1 (ko) 2013-10-18 2022-02-03 노바셉 이큅먼트 솔루션즈 단백질 정제

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713764A (de) * 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
GB1507198A (en) * 1974-04-12 1978-04-12 Squibb & Sons Inc Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4104266A (en) * 1977-04-14 1978-08-01 American National Red Cross Method for preparation of antihemophilic factor
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
US4294826A (en) * 1980-05-07 1981-10-13 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor
AT369263B (de) * 1980-08-27 1982-12-27 Immuno Ag Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
US4406886A (en) * 1983-01-14 1983-09-27 University Patents, Inc. Purification of antihemophilia factor VIII by precipitation with zinc ions
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate

Also Published As

Publication number Publication date
JPH0822879B2 (ja) 1996-03-06
ZA868516B (en) 1987-08-26
ES2051686T3 (es) 1994-07-01
ATE79266T1 (de) 1992-08-15
EP0221566A3 (en) 1987-10-07
US4739039A (en) 1988-04-19
AU6487286A (en) 1987-05-14
DE3686390D1 (de) 1992-09-17
EP0221566A2 (de) 1987-05-13
EP0221566B1 (de) 1992-08-12
CA1293941C (en) 1992-01-07
JPS62181220A (ja) 1987-08-08

Similar Documents

Publication Publication Date Title
DE3686390D1 (de) Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes.
DE69002427D1 (de) Verfahren zur herstellung eines konzentrats des faktor viii-von willebrand-faktor-komplexes der blutgerinnung aus vollplasma.
ATE325133T1 (de) Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
ATE276994T1 (de) Verfahren zur reinigung von milchsäure auf industrieller basis
ATE305011T1 (de) Verfahren zur herstellung von virusfreien thrombin zur bereitung von fibrinkleber aus menschlichem plasma-pool
DE69512416T2 (de) Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
ATE88987T1 (de) Verfahren und vorrichtung zur reinigung von wasser mittels polypyrrolidon.
EP0125520A3 (de) Verfahren und Anlage zur Rückgewinnung von einem oder von mehreren Bestandteilen aus einem Gasgemisch
DE69408047T2 (de) Wiedergewinnung von Zitronensäure aus unreinen Prozessströmen durch Zusatz von starken Säuren und ihren Salze
DE69409722T2 (de) Verfahren zur Herstellung von Diacerein
DE69311337D1 (de) Verfahren zur Reinigung von Proteinen
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
KR880000465A (ko) 순수한 알부민의 제조방법
ATE162218T1 (de) Verfahren zur herstellung eines virussicheren thrombinkonzentrates
ATE108171T1 (de) Reinigung von 1,1-dichlor-1-fluorethan.
EP0237981A3 (de) Verfahren zur Herstellung eines den Blutgerinnungsfaktor VIII enthaltenden, sterilen Präparates
Williams et al. Purification and properties of a procoagulant from peninsula tiger snake (Notechis ater niger) venom
ATE395428T1 (de) Verfahren zur isolierung und reinigung von lipidezellwandkomponenten
DE69525948T2 (de) Verfahren zur wiedergewinnung von zitronensäure
ATE35533T1 (de) Verfahren zur rueckgewinnung von reiner benzoesaeure.
JPH0345080B2 (de)
EP0238986A3 (de) Verfahren zur Herstellung eines den Blutgerinnungsfaktor VIII in ankonzentrierter Form enthaltenden Präparates
DE69202923D1 (de) Verfahren zur Reinigung von wässerigen Alkalimetallchloridlösungen durch Entfernung von Ammonium und Jod.
ATE138046T1 (de) Verfahren zur entfernung von abgelagerten verunreinigungen in einem organischen strom zur erzeugung reiner phosphorsäure
ATE136535T1 (de) Verfahren zur reinigung von 2-chloropropionsäure

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings